University of Miami Health System, Miller School of Medicine

University of Miami Health System Launches Remote Monitoring Televigilance Program for Select COVID-19 Patients

Program Allows for Safe Discharge of Some COVID-19 Patients and Monitored From Home

Newswise — The University of Miami Health System has launched the UHealth Televigilance program, allowing providers to remotely monitor and care for COVID-19 patients who might otherwise need to continue care in inpatient settings.

The program involves arming discharged patients with TytoCare home health devices, which they and their caregivers use to electronically transmit timely health status information. Providers monitor patients’ vital signs and can quickly address problems or triage patients who need higher levels of care.

“The UHealth Televigilance program intends to decrease length of hospital stay and prevent readmissions while freeing up hospital beds," said Sabrina Taldone, M.D., M.B.A., medical director of the UHealth Televigilance program and associate program director of the Internal Medicine Residency Program at the Miller School of Medicine. "Merging the benefits of telemedicine visits with the clinical accuracy obtained through recording patient vital signs and an extensive physical examination enhances the opportunity to closely monitor specific patients immediately after hospital discharge or ER release, thereby improving transitions of care."

The device regularly monitors patients’ temperature, blood pressure, heart rate, and oxygen saturation. If providers see data that concerns them, they can follow up with a telemedicine visit and conduct a thorough examination. The patient or caregiver uses device adapters to allow Dr. Taldone and other providers to examine the patient’s heart, lungs, skin, mouth, and ears.

The TytoCare device is integrated with Epic, UHealth’s Electronic Medical Record system. This allows UHealth to apply computer logic to patients’ clinical data, which also helps to alert providers when a value is out of normal range, according to David W. Reis, Ph.D., chief information officer at the University of Miami Health System.

“It brings another layer of data review and analysis for the patient, and makes it easier for our clinicians to rapidly respond when they see something that looks out of range,” Dr. Reis said.

UHealth began distributing the TytoCare devices to eligible patients on July 10. The plan is to distribute seven to 10 of the devices a week.

“Thus far, these devices have been given to the COVID-19 patients at higher risk of complications, such as those with co-morbidities or those discharged on home oxygen,” Dr. Taldone said.

A candidate for the technology might be a patient in the UHealth emergency department with COVID-19 pneumonia, who isn’t necessarily sick enough to be admitted to the hospital but would do well with a provider following up and making sure that the patient isn’t getting worse. Inpatients who are eligible for the program include those who have been hospitalized for a significant length of time and need close follow-up after discharge.

Miami resident Tomas Camacho and his son Thomas, who is caring for the elder Camacho, are using the TytoCare device.

Tomas Camacho was discharged from UHealth Tower with oxygen, after staying several days in the hospital with COVID-19 pneumonia. His son recalls feeling stressed when his 73-year-old father came home because he wasn’t sure how to monitor his progress.

“The [TytoCare] device has been amazing because we’ve been able to send all the information directly to the doctor, and she has contacted us and been very helpful in everything. It gives you a little ease,” Thomas Camacho said. “It’s pretty simple to use.”

Receiving vitals data from the device helped Dr. Taldone to intervene and prevent a readmission when the patient's blood pressure dropped precipitously and his oxygen saturation was low. “After reviewing records from his hospitalization in the electronic medical record, I initiated a telemedicine visit with the patient and his son," she said. "Importantly, our visit revealed the patient had re-started his home medications for hypertension. After adjusting his medications, his blood pressure improved.

"By seeing the patient, I noticed the nasal cannula was not properly placed on his face. They also needed education on how to appropriately titrate his home oxygen. Therefore, we were able to help the patient avoid a call to 911 and a hospital readmission.”

Patients or caregivers need to have access to a smartphone or tablet and a Wi-Fi network. Once they’re trained in how to use the device, patients or caregivers need to be able to perform vitals measurements using the technology.

"As we gain a better understanding of the UHealth Televigilance program’s full potential, we hope to improve patient transitions of care and to provide a higher quality of patient care at lower cost,” said Dr. Taldone.



Filters close

Showing results

110 of 3321
Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.

Released: 17-Sep-2020 5:50 PM EDT
AERA and OECD to Co-Host Webinar on Education Research Worldwide in a Covid and Post-Covid World
American Educational Research Association (AERA)

The American Educational Research Association (AERA) and the Organisation for Economic Co-operation and Development (OECD) will co-host a webinar on “Education Research Worldwide in a Covid and Post-Covid World” at 9:30-11:00 am EDT Wednesday, September 23.

Newswise: 243232_web.jpg
Released: 17-Sep-2020 4:20 PM EDT
Study shows first proof that a safer UV light effectively kills virus causing COVID-19
Hiroshima University

A study conducted by Hiroshima University researchers found that using Ultraviolet C light with a wavelength of 222 nanometers which is safer to use around humans effectively kills SARS-CoV-2 -- the first research in the world to prove its efficacy against the virus that causes COVID-19.

Newswise:Video Embedded american-academy-of-dermatology-honors-detroit-physician-iltefat-h-hamzavi-with-national-patient-care-hero-award
Released: 17-Sep-2020 4:00 PM EDT
American Academy of Dermatology honors Detroit physician Iltefat H. Hamzavi with national “Patient Care Hero” award
American Academy of Dermatology

The American Academy of Dermatology has named board-certified dermatologist Iltefat H. Hamzavi, MD, FAAD, a Patient Care Hero for his innovative use of light therapy to sanitize masks needed by frontline health care workers.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Sep-2020 11:00 AM EDT Released to reporters: 17-Sep-2020 3:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Sep-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 17-Sep-2020 3:05 PM EDT
Does a New Study Give Evidence that the Coronavirus Was Made In a Lab?

Scientists in a new paper make strong claims regarding evidence that the COVID-19 virus did not originate in nature—the prevailing theory—but instead was made in a lab. According to six leading experts in evolutionary biology and infectious disease consulted by Newsweek, the paper offers no new information, makes numerous unsubstantiated claims and its scientific case is weak.

Showing results

110 of 3321